Position in TRVI
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$192,084
-$265,021 QoQ
Shares Held
16,101
-55.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in TRVI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $192,084 | 16,101 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $457,105 | 36,510 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $379,203 | 41,443 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $694,274 | 126,924 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $798,351 | 126,924 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $553,534 | 134,353 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $241,180 | 72,210 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $215,185 | 72,210 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $78,435 | 22,735 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $40,072 | 18,382 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||